X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ANGIOLOGY

期刊標題檢索 ANGIOLOGY 最新評論: May I ask how long it will take for the final repair to have results? (2024-10-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ANGIOLOGY]您好,您是該頁面的第 22814 位訪客。

期刊簡介
期刊名稱ANGIOLOGY ANGIOLOGY
LetPub Score
6.4
50 ratings
Rate

Reputation
7.5

Influence
4.9

Speed
9.4

期刊簡稱ANGIOLOGY
ISSN0003-3197
E-ISSN1940-1574
h-index59
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.500.6950.953
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q299 / 387

自引率 (2023-2024)15.40%自引率趨勢
掲載範囲
A presentation of original, peer-reviewed original articles, review and case reports relative to all phases of all vascular diseases, Angiology (ANG) offers more than a typical cardiology journal. With approximately 1000 pages per year covering diagnostic methods, therapeutic approaches, and clinical and laboratory research, ANG is among the most informative publications in the field of peripheral vascular and cardiovascular diseases. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 13 days
官方網站http://ang.sagepub.com/
在線稿件提交https://us.sagepub.com/en-us/nam/angiology/journal201786#submission-guidelines
開放訪問No
出版商SAGE Publications Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1950
每年文章數134每年文章數趨勢
黃金OA百分比4.55%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PERIPHERAL VASCULAR DISEASESCIEQ237/96
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0003-3197%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【ANGIOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CIRCULATIONH-index: 570

    CiteScore: 45.70
    CIRCULATION RESEARCHH-index: 306

    CiteScore: 29.60
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYH-index: 251

    CiteScore: 15.60
    HYPERTENSIONH-index: 246

    CiteScore: 15.90
    International Journal of StrokeH-index: 59

    CiteScore: 13.90
    JOURNAL OF THROMBOSIS AND HAEMOSTASISH-index: 154

    CiteScore: 24.30
    THROMBOSIS AND HAEMOSTASISH-index: 178

    CiteScore: 11.90
    ATHEROSCLEROSISH-index: 159

    CiteScore: 9.80
    HYPERTENSION RESEARCHH-index: 78

    CiteScore: 7.40
    CURRENT HYPERTENSION REPORTSH-index: 63

    CiteScore: 10.50
    學科內最受檢索的期刊 頁面查看次數
    CIRCULATION118516
    CIRCULATION RESEARCH93192
    HYPERTENSION80491
    ATHEROSCLEROSIS77484
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY66788
    JOURNAL OF HYPERTENSION51919
    THROMBOSIS RESEARCH43999
    HYPERTENSION RESEARCH42958
    THROMBOSIS AND HAEMOSTASIS38957
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS35901
  •  

    ANGIOLOGY ANGIOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [ANGIOLOGY] 的評論撰寫評論
作者: lt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 23:11:45 評論於
May I ask how long it will take for the final repair to have results?
(0) 讚! | lt

作者: 若枫三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-22 23:39:50 評論於
Can you please translate the following paragraph into English and Japanese, using ":" and ":" as headers?
(0) 讚! | 若枫三岁啦

作者: 百花邵美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 08:39:26 評論於
Xiao Xiu has been gone for two months, what's going on?
(0) 讚! | 百花邵美

作者: 雨巷少年绮梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 23:20:12 評論於
How long does the final approval usually take?
(0) 讚! | 雨巷少年绮梅

作者: Crystal Bertram


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-13 13:50:42 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as titles: Sought after
(0) 讚! | Crystal Bertram

作者: 太山天震


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-07 23:35:24 評論於
How long does it usually take for awaiting reviewer selection after submission?
(0) 讚! | 太山天震

作者: 仲夏俊力


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-06 14:20:41 評論於
How long did the final approval take?
(0) 讚! | 仲夏俊力

作者: 安兰酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-29 10:27:23 評論於
Please translate the following paragraph into English and Japanese, and title them respectively ":" and ":"
(0) 讚! | 安兰酱吖

作者: 宗室春荣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-18 23:52:36 評論於
Reject the manuscript within 1-2 days
(0) 讚! | 宗室春荣

作者: 明冠梦泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 13:41:33 評論於
Mine is the same
(0) 讚! | 明冠梦泽

作者: Ingrid Belle


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-18 19:45:40 評論於
It has been a month since submission, and the status is still "Awaiting Reviewer Response"
(0) 讚! | Ingrid Belle

作者: Ingrid Belle


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-14 19:46:32 評論於
It has been a month since I submitted my work, still awaiting reviewer response... What's going on?
(0) 讚! | Ingrid Belle

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:35:10 評論於
Please translate the following paragraph into English and Japanese, with titles ":" and ":"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:27:20 評論於
Please translate the following paragraph into English and Japanese, and title them as ":" and ":" respectively
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:41:05 評論於
What is the minimum number of keywords required?
(0) 讚! | 修然小公主

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 17:58:55 評論於
What is the maximum number of keywords allowed?
(0) 讚! | 魂魄彦露

作者: 血天树潼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-28 19:26:16 評論於
Which magazine did it ultimately get submitted to?
(0) 讚! | 血天树潼

作者: 藤原春岚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-13 22:33:05 評論於
The accuracy rate should be less than 25%
(0) 讚! | 藤原春岚

作者: 藤原春岚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-11 22:29:55 評論於
Submission success rate: 25.0 Experience sharing: I had three articles rejected instantly before finally being accepted by a higher journal
(0) 讚! | 藤原春岚

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 19:52:47 評論於
High accuracy of hitting the target
(0) 讚! | Oliver Jerry

作者: Jo Senior


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-20 21:38:46 評論於
Review Speed: 2.0
Experience Sharing: This journal has a pretty fast rejection time. If it is not suitable, it will usually be rejected within a week. However, if it is sent for review, it is more agonizing. The first review cycle should be about 1 and a half months. However, in one scenario, only two reviewers should review the manuscript the first time. If the opinions of the two reviewers are consistent, then there will be a first review opinion in about 1 and a half months. But if the opinions of the two reviewers are not consistent, it will be sent to other reviewers again, which will add another 1 and a half months. Therefore, some may take more than 3 months to get a first review opinion, while others may get a review opinion in about 1 and a half months
(0) 讚! | Jo Senior

作者: Dana Alcott


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-10 16:28:54 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Experience sharing: Rejected within one week, it is recommended to submit to other magazines under the same publisher. This magazine may prefer peripheral vascular diseases and interventions
(0) 讚! | Dana Alcott

作者: 迎丝姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-16 17:59:23 評論於
The self-quoting rate has increased slightly, but it is still within a controllable range. The IF for next year may decrease
(0) 讚! | 迎丝姑娘

作者: Eddie


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-16 16:29:06 評論於
The publication fees for this journal have gone slightly up, but they are still within an acceptable price range. The IF for this journal may drop next year, so perhaps the costs will decrease as well.

(0) 讚! | Eddie

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 21:22:44 評論於
3-point edge, hoping to maintain stability, a slight increase is also good
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [ANGIOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*